Muse Cell Therapy — Next-Generation Regenerative Medicine

Muse Cells are isolated from healthy donor bone marrow or umbilical cord tissue, then rigorously tested for safety, purity, and potency before administration.

Muse Cells are delivered intravenously in a simple, minimally invasive outpatient procedure. No surgery, no anesthesia, and no lengthy recovery time required.

Once in the bloodstream, Muse Cells are guided by S1P signals to migrate directly to sites of injury or disease throughout the body, crossing barriers including the blood-brain barrier.

At the site of damage, Muse Cells differentiate into the specific cell type needed — neurons, cardiomyocytes, hepatocytes, or skin cells — and integrate into the host tissue to restore function.

Stroke recovery, ALS, Parkinson’s disease, spinal cord injury, traumatic brain injury, multiple sclerosis, and dementia. Muse Cells cross the blood-brain barrier and differentiate into neurons to restore neural function.

Heart failure, myocardial infarction, and ischemic heart disease. Muse Cells differentiate into cardiomyocytes and endothelial cells, repairing damaged heart muscle and restoring vascular integrity.

Rheumatoid arthritis, lupus, Crohn’s disease, and multiple sclerosis. Muse Cells modulate the immune system, reducing chronic inflammation and halting autoimmune attacks on healthy tissue.

Type 1 and Type 2 diabetes, liver disease, and kidney failure. Muse Cells can differentiate into insulin-producing beta cells, hepatocytes, and renal cells to restore organ function.

Osteoarthritis, cartilage damage, sports injuries, and degenerative disc disease. Muse Cells promote cartilage regeneration, reduce joint inflammation, and restore mobility.

Chronic wounds, diabetic ulcers, burns, and radiation-damaged skin. Muse Cells accelerate tissue repair, reduce scarring, and promote healthy skin regeneration.

COPD, pulmonary fibrosis, and post-COVID lung damage. Muse Cells reduce pulmonary inflammation, promote alveolar repair, and improve respiratory function.

Systemic cellular rejuvenation, improved energy levels, cognitive enhancement, and overall vitality restoration. Muse Cells replenish the body’s natural repair mechanisms depleted by aging.

Muse Cells possess immune privilege properties, meaning they can be administered from any donor without the need for tissue matching or immunosuppressive drugs, dramatically reducing treatment complexity and risk.

Unlike embryonic stem cells or iPSCs, Muse Cells are not genetically manipulated. They are naturally present in adult tissues, making them intrinsically safe and ethically uncontroversial.

Muse Cells migrate autonomously to damaged tissue via sphingosine-1-phosphate (S1P) signaling. A simple IV infusion is sufficient to deploy these cells throughout the body with no surgical implantation needed.

Unlike iPSCs or embryonic stem cells, Muse Cells have demonstrated no tumor formation in extensive preclinical and clinical studies, providing a significantly safer profile for therapeutic use.

Delivered via simple IV infusion, Muse Cell Therapy requires no surgery, no general anesthesia, and no hospitalization. Most patients complete treatment in a single outpatient visit.

A single Muse Cell infusion can simultaneously address multiple damaged organ systems, making it uniquely effective for patients with complex, multi-system conditions.

Clinical studies show that Muse Cells integrate into host tissues and continue to provide regenerative benefits for months to years after a single treatment, offering sustained improvement.

Muse Cell Therapy has been evaluated in multiple Phase 1, 2, and 3 clinical trials in Japan and internationally, demonstrating an excellent safety profile with no serious adverse events reported.